AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitaxa M 50mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (850mg)

Overview Sitaxa M 50mg/850mg Tablet

Diabex Duo 50mg/850mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like kidney disease and vision loss, potentially lowering heart attack and stroke risk. Diabex Duo 50mg/850mg may be used independently or with other diabetes treatments. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering health status, blood sugar levels, and concurrent medications. Taking it with food minimizes stomach upset. Consistent daily dosing is crucial for efficacy; discontinue only under physician guidance. Maintaining the prescribed diet and exercise plan is vital for diabetes control; lifestyle choices are key. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a possibility, especially with concurrent insulin or sulfonylurea use; learn hypoglycemia recognition and management. This medication isn't suitable for all. Inform your doctor of any kidney, liver, heart, or pancreatic issues, excessive alcohol consumption, or pregnancy/breastfeeding before starting. Disclose all other medications to ensure safe interaction. Alcohol should be limited due to its potential to lower blood sugar. Your physician will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Sitaxa M 50mg/850mg Tablet

No text provided to rephrase.

Uses of Sitaxa M 50mg/850mg Tablet

Managing type 2 diabetes

Major Benefits of Sitaxa M 50mg/850mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the Sitaxa M 50mg/850mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Sitaxa M 50mg/850mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaxa M 50mg/850mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Sitaxa M 50mg/850mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sitaxa M 50mg/850mg Tablet works:

Sitaxa M, a 50mg/850mg tablet, combines sitagliptin and metformin to manage blood sugar. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaxa M 50mg/850mg Tablet and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitaxa M 50mg/850mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitaxa M 50mg/850mg tablets while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sitaxa M 50mg/850mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitaxa M 50mg/850mg tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverUNSAFE

The use of Sitaxa M 50mg/850mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitaxa M 50mg/850mg Tablet :

Should you forget a Sitaxa M 50mg/850mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaxa M 50mg/850mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitaxa M 50mg/850mg Tablet

Sitaxa M 50mg/850mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitaxa M 50mg/850mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaxa M 50mg/850mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitaxa M 50mg/850mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitaxa M 50mg/850mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitagliptin/Metformin 50mg/850mg tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding this medication in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaxa M 50mg/850mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitaxa M 50mg/850mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitaxa M 50mg/850mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sitaxa M 50mg/850mg tablets is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/850mg tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). While rare, this risk is higher in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitaxa M 50mg/850mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaxa M 50mg/850mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaxa M 50mg/850mg tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitaxa M 50mg/850mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitaxa M 50mg/850mg Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Sitaxa M 50mg/850mg) can cause lactic acidosis, a serious medical emergency involving excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitaxa M 50mg/850mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitaxa M 50mg/850mg Table...
247